Skip to main content
E

Epi Biotech Co., Ltd. — Investor Relations & Filings

Ticker · 446440 ISIN · KR7446440000 KO Professional, scientific and technical activities
Open in API
Filings indexed 62 across all filing types
Latest filing 2025-05-12 Major Shareholding Noti…
Country KR South Korea
Listing KO 446440

About Epi Biotech Co., Ltd.

https://epibiotech.com/en/

Epi Biotech Co., Ltd. is a biopharmaceutical company focused on the research and development of treatments for hair loss. The company utilizes a large genomic database and AI-driven drug discovery platforms to advance its pipeline, which includes cell and antibody therapeutics for hair restoration. In addition to its primary focus, Epi Biotech conducts R&D in skin regeneration. The company also provides specialized preclinical Contract Research Organization (CRO) services, offering expertise in hair loss research and efficacy evaluation.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details the acquisition and disposal of shares by Korea Investment Partners and its special related parties in the company EpiBiotech. This document is a formal disclosure of ownership changes, which falls under the 'Major Shareholding Notification' category.
2025-05-12 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a third-party paid-in capital increase via convertible preferred shares). It details the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2025-04-24 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a decision for a third-party paid-in capital increase (유상증자결정) by EpiBiotech. This document details the number of shares, issuance price, purpose of funds (operating funds), and the specific third-party investor (Korea Investment Core Competency Leverage II Fund). This type of filing is a standard regulatory disclosure for capital changes and share issuance in the Korean market, which falls under the 'Share Issue/Capital Change' category.
2025-04-16 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official announcement of the results of a General Meeting of Shareholders (정기주주총회 결과). It details the approval of financial statements, dividend decisions, and the election of auditors. This falls under the category of Declaration of Voting Results & Voting Rights Announcements, as it reports the outcomes of the shareholder meeting.
2025-03-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea. This type of filing is required when an individual or entity acquires a significant stake in a company (typically 5% or more) or changes their holdings significantly. In the provided taxonomy, this corresponds to a 'Major Shareholding Notification' (MRQ).
2025-03-26 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a third-party paid-in capital increase for convertible preferred shares). It details the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2025-03-19 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.